ClinicalTrials.Veeva

Menu

Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients (SWAP)

University of Tennessee logo

University of Tennessee

Status and phase

Completed
Phase 3

Conditions

Pain, Acute

Treatments

Drug: cannabidiol
Drug: acetaminophen 500mg and ibuprofen 200mg combo
Drug: placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT04271917
20-07123-XP

Details and patient eligibility

About

The purpose of this study is to evaluate the analgesic effects of cannabidiol for patients who have undergone simple tooth extraction. Participants will be randomized to one of four arms: treatment-as-usual (TAU), cannabidiol 17mg/mL, cannabidiol 37mg/mL, or placebo.

Enrollment

68 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presenting for an operatory appointment at University of Tennessee Health Science Center College of Dentistry Oral and Maxillofacial Surgery Department
  • Operation must be a simple tooth extraction which does not result in an opioid prescription
  • 18 years of age or older
  • Have regular and direct access to a device that can send and receive texts and willing to accept any associated charges for 24 text messages

Exclusion criteria

  • Contraindication to ibuprofen
  • Contraindication to acetaminophen
  • Contraindication to cannabidiol or hemp oil
  • Contraindication to peppermint oil
  • Contraindication to almond or other tree nuts
  • Currently taking a form of cannabidiol and unwilling to stop use for one week post surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

68 participants in 4 patient groups, including a placebo group

Treatment As Usual (TAU)
Active Comparator group
Description:
Participants will receive a 5-day supply of acetaminophen 500mg and ibuprofen 200mg. Instructions for use: Take one tablet of each medication at the same time every 4-6 hours as needed for pain.
Treatment:
Drug: acetaminophen 500mg and ibuprofen 200mg combo
Placebo
Placebo Comparator group
Description:
Participants will receive a 5-day supply (15mL) of inactive placebo in a dropper vial. Instructions for use: Place 0.5mL of oil under tongue for 30 seconds then swallow. Use every 4-6 hours as needed for pain.
Treatment:
Drug: placebo
CBD 17mg/mL
Experimental group
Description:
Participants will receive a 5-day supply (15mL) of cannabidiol 17mg/mL. Instructions for use: Place 0.5mL of oil under tongue for 30 seconds then swallow. Use every 4-6 hours as needed for pain.
Treatment:
Drug: cannabidiol
CBD 37 mg/mL
Experimental group
Description:
Participants will receive a 5-day supply (15mL) of cannabidiol 37mg/mL. Instructions for use: Place 0.5mL of oil under tongue for 30 seconds then swallow. Use every 4-6 hours as needed for pain.
Treatment:
Drug: cannabidiol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems